At the news
? MIXEDIMPACT 5/10 8-K filed Aug 5, 2026 at 07:04 ET
Insulet reported Q2 2026 revenue of $801.7M (+23.5% YoY) and adjusted EPS of $1.66, beating consensus estimates by 14.3%, but lowered FY 2026 U.S. Omnipod constant currency growth guidance from 20-22% to 17-19%, signaling a meaningful deceleration in the domestic business.
- Q2 2026 revenue $801.7M vs $649.1M YoY, +23.5% as reported, +22.7% constant currency
- GAAP EPS $1.37 (diluted); adjusted EPS $1.66, beating consensus $1.45 by 14.3%
- U.S. Omnipod revenue $544.1M (+20.1% YoY); International Omnipod $251.8M (+35.5% YoY, +32.9% constant currency)
- FY 2026 U.S. Omnipod constant currency growth guidance cut to 17-19% from prior 20-22%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access